These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6248083)

  • 1. First clinical experience with a new neuromuscular blocker pipecurium bromide.
    Alánt O; Darvas K; Pulay I; Weltner J; Bihari I
    Arzneimittelforschung; 1980; 30(2a):374-9. PubMed ID: 6248083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report on clinical test of pipecurium bromide.
    Wittek L; Gecsényi M; Barna B; Hargitay Z; Adorján K
    Arzneimittelforschung; 1980; 30(2a):379-83. PubMed ID: 6248084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with a new steroid muscle relaxant: pipecurium bromide.
    Bunjatjan AA; Miheev VI
    Arzneimittelforschung; 1980; 30(2a):383-5. PubMed ID: 6248085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiration paralysing and circulatory effects of a new non-depolarizing relaxant, pipecurium bromide, in anaesthetized dogs.
    Pulay I; Alánt O; Darvas K; Weltner J; Zétény Z
    Arzneimittelforschung; 1980; 30(2a):358-60. PubMed ID: 6248078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical study of pipecurium bromide and pancuronium bromide.
    Boros M; Szenohradszky J; Marosi G; Tóth I
    Arzneimittelforschung; 1980; 30(2a):389-93. PubMed ID: 6248087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulatory effects of pipecurium bromide during anaesthesia of patients with severe valvular and ischaemic heart diseases.
    Barankay A
    Arzneimittelforschung; 1980; 30(2a):386-9. PubMed ID: 6248086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide.
    Kárpáti E; Biró K
    Arzneimittelforschung; 1980; 30(2a):346-57. PubMed ID: 6155921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the steroid muscle relaxant pipecurium bromide on the acetylcholinesterase activity of red blood cells in vitro.
    Simon G; Biró K; Kárpáti E; Tuba Z
    Arzneimittelforschung; 1980; 30(2a):360-3. PubMed ID: 6248079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On some properties of a new steroid curare-like compound pipecurium bromide.
    Alyautdin RN; Buyanov VV; Fisenko VP; Lemina EJ; Muratov VK; Samoilov DN; Shorr VA
    Arzneimittelforschung; 1980; 30(2a):355-7. PubMed ID: 6248077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myorelaxants and intracranial pressure (ICP) in neurosurgery. Preliminary clinical results of pipecurium bromide (Arduan) on ICP and on cerebral perfusion pressure (CPP)].
    Di Giugno G; Sanfilippo M; Orfei P; Rosa G
    Minerva Anestesiol; 1992 Apr; 58(4 Suppl 1):83-6. PubMed ID: 1320223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans.
    Tassonyi E; Szabó G; Vereczkey L
    Arzneimittelforschung; 1981; 31(10):1754-6. PubMed ID: 6274362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pipecurium bromide (Arduan)--new steroid non-depolarizing muscle relaxant.
    Kobielski J; Wysocki M; Orlicz P; Trzaski M; Gajewski K
    Ther Hung; 1986; 34(1):45-9. PubMed ID: 2833823
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of different doses of pipecuronium bromide during nitrous-oxide-fentanyl anaesthesia in adult surgical patients.
    Sanfilippo M; Fierro G; Vilardi V; Rosa G; De Gregorio AL; Gasparetto A
    Eur J Anaesthesiol; 1992 Jan; 9(1):49-53. PubMed ID: 1310464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of safety tests with pipecurium bromide, a new neuromuscular blocking agent.
    Cholnoky E
    Arzneimittelforschung; 1980; 30(2a):370-4. PubMed ID: 6248082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.
    Wierda JM; Richardson FJ; Agoston S
    Anesth Analg; 1989 Mar; 68(3):208-13. PubMed ID: 2537588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in human serum.
    Szabó G; Tassonyi E
    Arzneimittelforschung; 1981; 31(6):1013-5. PubMed ID: 6266429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical, electromyographic and electromechanographic studies of the nondepolarizing muscle relaxant pipecurium bromide (Arduan)].
    Stoianov E; Shtŭrbova M; Marinova M
    Khirurgiia (Sofiia); 1988; 41(5):35-7. PubMed ID: 2851068
    [No Abstract]   [Full Text] [Related]  

  • 20. Disposition of pipecurium bromide in rats.
    Vereczkey L; Szporny L
    Arzneimittelforschung; 1980; 30(2a):364-6. PubMed ID: 6248080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.